RxDoctor Payments Data

Lily Zhang

Ophthalmology · Miami, FLNPI 1043771850

Payments from drug & device makers

$8,416in general payments, 2019–2025

Across 92 payments — averaging $91.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$2K
  • Glaukos Corporation$2K
  • Alcon$2K
  • Bausch & Lomb Americas Inc.$486
  • Johnson & Johnson Surgical Vision, Inc.$344
  • ANI Pharmaceuticals, Inc.$310
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$1,25019%
  • Travel & lodging$1803%
  • Food & beverage$4,98678%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,416 in reported general payments places this provider in the 80th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida

Medicare billing

Part B allowed, 2024
$60,370
Medicare patients
253
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine27$19,242
Prednisolone Acetate156$7,660
MoxifloxacinMoxifloxacin Hcl85$2,611
Fluorometholone31$2,404
ValacyclovirValacyclovir Hcl31$1,921
Ketorolac Tromethamine54$1,343
Loteprednol Etabonate12$1,286
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat52$688
Timolol Maleate15$409
Brimonidine Tartrate25$393
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim45$349
Latanoprost46$298
ErythromycinErythromycin Base22$243
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11$180

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →